PERNIX THERAPEUTICS HLDGS IN's ticker is PTX and the CUSIP is 71426V108.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2016 | $1,002,000 | +215.1% | 1,610,542 | +126.7% | 0.00% | – |
Q2 2016 | $318,000 | -80.0% | 710,276 | -53.2% | 0.00% | – |
Q1 2016 | $1,592,000 | -58.2% | 1,516,585 | +17.5% | 0.00% | -100.0% |
Q4 2015 | $3,807,000 | +6.5% | 1,290,434 | +14.1% | 0.00% | 0.0% |
Q3 2015 | $3,574,000 | -45.2% | 1,131,074 | +2.7% | 0.00% | 0.0% |
Q2 2015 | $6,522,000 | -41.5% | 1,101,650 | +5.7% | 0.00% | -50.0% |
Q1 2015 | $11,141,000 | +22.0% | 1,042,145 | +7.1% | 0.00% | +100.0% |
Q4 2014 | $9,133,000 | +25.8% | 972,614 | +2.9% | 0.00% | 0.0% |
Q3 2014 | $7,260,000 | -1.1% | 945,252 | +15.6% | 0.00% | 0.0% |
Q2 2014 | $7,342,000 | +146.2% | 817,561 | +46.7% | 0.00% | 0.0% |
Q1 2014 | $2,982,000 | +149.1% | 557,391 | +17.4% | 0.00% | – |
Q4 2013 | $1,197,000 | +12.7% | 474,933 | +21.6% | 0.00% | – |
Q3 2013 | $1,062,000 | -21.0% | 390,541 | +4.9% | 0.00% | – |
Q2 2013 | $1,344,000 | – | 372,224 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|